menu close
www.ringtx.com

Ring Therapeutics Stock

Company Profile:

Ring Therapeutics is a biotechnology company pioneering gene therapies by leveraging the human commensal virome. Their Anellogyâ„¢ platform utilizes naturally occurring anelloviruses to develop viral-based therapies with tissue specificity, payload versatility, potency, and redosability. This innovative approach aims to address significant unmet medical needs across various therapeutic areas.

Sign up for SecondMarket® to view the market and buy or sell Ring Therapeutics Stock
Buy + Sell
Leverage Your Equity to Help Achieve More.

Ring Therapeutics Management Team

  • Chief People Officer

    Megan Woods

  • CEO

    Christopher McNulty

  • Board Member

    Travis Wilson

  • CTO

    Konstantin Konstantinov

  • Board Member

    Francois Nader

  • Chief Scientific Officer

    Geoffrey Parsons

  • Board Member

    Lynne Parshall

  • Board Member

    Hari Pujar

  • Board Member

    Avak Kahvejian

  • Chief Medical Officer

    Chistopher Wright

Learn More About Ring Therapeutics Stock

Buy Ring Therapeutics Stock
01

Ring Therapeutics stock does not trade on public stock exchanges. Ring Therapeutics stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Ring Therapeutics stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.

Learn more about the secondary market for private company shares on the investors page.

Sell Ring Therapeutics Stock
02

Ring Therapeutics Stock does not trade on public stock exchanges. In order to sell Ring Therapeutics shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.

Learn more about NPM services for selling privately held stock on the Employee Shareholders page.

Read more about how to sell private company stock on the private secondary market:

Ring Therapeutics Stock Price
03

Ring Therapeutics does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the Tape D™ database from Nasdaq Private Market, you can view Ring Therapeutics share price and other valuable private market data.

Read more about secondary market private company stock prices:

Ring Therapeutics Stock Ticker Symbol
04

There is no ticker symbol for Ring Therapeutics stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.

Criteria to Sell Ring Therapeutics Stock
05

Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Ring Therapeutics stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.

Learn more about selling privately held stock on the Employee Shareholders page.

Read more about how to sell shares of a private company and eligibility for selling privately held stock:

Criteria to Buy or Invest in Ring Therapeutics Stock
06

Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Ring Therapeutics stock, you need to be an accredited entity or institutional investor.

Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.

Ring Therapeutics Stock Settlement
07

Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.

To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.

Ring Therapeutics IPO
08

Ring Therapeutics is a private company and has not had an IPO. There is currently no Ring Therapeutics IPO price. Get started to begin exploring the Nasdaq Private Market Tape D™ database and gain access to actionable data related to Ring Therapeutics IPO.

Learn more about Tape D™ private company stock data for institutional investors on the on the Tape D™ Product Page.

Sign up for SecondMarket® to view the market and buy or sell Ring Therapeutics Stock
Buy + Sell

*All trademarks are the property of their respective owner(s). Unless expressly stated otherwise, companies listed on this site are not sponsoring, endorsing, or otherwise affiliated with, Nasdaq Private Market, LLC, and none of the statements on this website should be attributed to a listed company.

Other Companies

Roman Health Ventures-Logo

Ro

Healthcare technology for a patient-centric healthcare system.

Insitro-Logo

insitro

Drug discovery and development company.

Eikon Therapeutics Inc-Logo

Eikon Therapeutics

Uses revolutionary technology to discover novel treatments for life-threatening diseases.

Indigoag-Logo

Indigo Agriculture

Improves grower profitability, environmental sustainability, and consumer health through the use of natural microbiology and digital technologies.

Weareresilience-Logo

Resilience

Operates as technology-focused biomanufacturing company dedicated to broadening access to complex medicines.

Virta Health-Logo

Virta Health

Online specialty medical clinic focused on reversing type 2 diabetes.

Color-Logo

Color Genomics

Physician-ordered genetic testing with comprehensive support, utilizing advanced software and a certified laboratory.

Medable Inc.-Logo

Medable

Global cloud platform for decentralized clinical trials.

Rakuten Medical-Logo

Rakuten Medical

Developing precision, cell-targeting investigational therapies on its Illuminox platform, which have shown rapid and selective cell killing and tumor necrosis in pre-clinical studies.

Source: Nasdaq Private Market Tape D®